A Sequential Two-Part, Open-Label Study in Healthy Male and Female Subjects

NCT02604914 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

36

Enrollment

INDUSTRY

Sponsor class

Conditions

Parkinson's Disease

Interventions

DRUG: ND0612
DRUG: LCIG

Sponsor

NeuroDerm Ltd.

Collaborators

[object Object]